No Data
Express News | Edwards Lifesciences Corp Shares Hit Session Low, Falling Sharply in Afternoon Volume Pickup, Last Down 1.7% at $68.11
Edwards Launches SAPIEN 3 With Alterra Prestent in Europe for Transcatheter Pulmonic Valve Implantation
Watching Edwards Lifesciences; Traders Circulate Unconfirmed M&A Blog Comments Suggesting The Co Is Engaged In Takeover Chatter
BofA Securities Downgrades Edwards Lifesciences(EW.US) to Hold Rating, Cuts Target Price to $75
BofA Securities analyst Travis Steed downgrades $Edwards Lifesciences(EW.US)$ to a hold rating, and adjusts the target price from $105 to $75.According to TipRanks data, the analyst has a success
Unusual Options Activity: ETSY, SWKS and Others Attract Market Bets, ETSY V/OI Ratio Reaches 119.8
EST Sep 13th Morning Delivery - In the last two hours of trading, 8 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Truist Financial Downgrades Edwards Lifesciences(EW.US) to Hold Rating
Truist Financial analyst Richard Newitter downgrades $Edwards Lifesciences(EW.US)$ to a hold rating.According to TipRanks data, the analyst has a success rate of 58.8% and a total average return of 16